Showing results (81-90 of 319) with videos related to
Sort By:
Pageof 32
Lung Cancer (Amsterdam, Netherlands)|December 27, 2011
Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107)Thierry Jahan, Lin Gu, Robert Kratzke, et al.American Journal of Clinical Oncology|June 3, 2011
Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancerAaron W Pederson, Joseph K Salama, Mary Ellen Witt, et al.Head & Neck|February 27, 2010
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongueAaron W Pederson, Daniel J Haraf, Mary-Ellyn Witt, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2010
A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602)Antonius A Miller, Herbert Pang, Lydia Hodgson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckRoy S Herbst, Matthew Arquette, Dong M Shin, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2010
Chemoreirradiation for recurrent salivary gland malignanciesAaron W Pederson, Daniel J Haraf, Elizabeth A Blair, et al.Cancer Biology & Therapy|April 26, 2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinomaEdwin M Posadas, Samir Undevia, Elizabeth Manchen, et al.Cancer Chemotherapy and Pharmacology|May 17, 2005
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancerApurva A Desai, Hedy L Kindler, David Taber, et al.Lung Cancer (Amsterdam, Netherlands)|January 8, 2014
Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904Joseph K Salama, Herbert Pang, Jeffrey A Bogart, et al.Molecular Therapy. Oncology|August 8, 2025
Erratum: Oncolytic adenovirus inhibits TNBC tumor growth/metastasis in mice by targeting TGF-β and overexpressing GM-CSFNguyễn Thị Thanh Nhàn, Soon Cheon Shin, Beniamin Filimon, et al.Pageof 32